These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 36728712)

  • 21. Novel 8-Substituted Coumarins That Selectively Inhibit Human Carbonic Anhydrase IX and XII.
    Buran K; Bua S; Poli G; Önen Bayram FE; Tuccinardi T; Supuran CT
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30857344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective inhibition of carbonic anhydrase IX and XII by coumarin and psoralen derivatives.
    Meleddu R; Deplano S; Maccioni E; Ortuso F; Cottiglia F; Secci D; Onali A; Sanna E; Angeli A; Angius R; Alcaro S; Supuran CT; Distinto S
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):685-692. PubMed ID: 33602041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A class of carbonic anhydrase IX/XII - selective carboxylate inhibitors.
    Alhameed RA; Berrino E; Almarhoon Z; El-Faham A; Supuran CT
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):549-554. PubMed ID: 31967484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitigating the resistance of MCF-7 cancer cells to Doxorubicin under hypoxic conditions with novel coumarin based carbonic anhydrase IX and XII inhibitors.
    Abdelaal HI; Mohamed AR; Abo-Ashour MF; Giovannuzzi S; Fahim SH; Abdel-Aziz HA; Supuran CT; Abou-Seri SM
    Bioorg Chem; 2024 Nov; 152():107759. PubMed ID: 39213797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of 3-sulfamoyl coumarins against cancer-related IX and XII isoforms of human carbonic anhydrase as well as cancer cells leads to the discovery of 2-oxo-2H-benzo[h]chromene-3-sulfonamide - A new caspase-activating proapoptotic agent.
    Dar'in D; Kantin G; Kalinin S; Sharonova T; Bunev A; Ostapenko GI; Nocentini A; Sharoyko V; Supuran CT; Krasavin M
    Eur J Med Chem; 2021 Oct; 222():113589. PubMed ID: 34147910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel library of saccharin and acesulfame derivatives as potent and selective inhibitors of carbonic anhydrase IX and XII isoforms.
    Carradori S; Secci D; De Monte C; Mollica A; Ceruso M; Akdemir A; Sobolev AP; Codispoti R; De Cosmi F; Guglielmi P; Supuran CT
    Bioorg Med Chem; 2016 Mar; 24(5):1095-105. PubMed ID: 26810710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation on Hydrazonobenzenesulfonamides as Human Carbonic Anhydrase I, II, IX and XII Inhibitors.
    Moi D; Vittorio S; Angeli A; Balboni G; Supuran CT; Onnis V
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, biological activity and multiscale molecular modeling studies of bis-coumarins as selective carbonic anhydrase IX and XII inhibitors with effective cytotoxicity against hepatocellular carcinoma.
    Kurt BZ; Dag A; Doğan B; Durdagi S; Angeli A; Nocentini A; Supuran CT; Sonmez F
    Bioorg Chem; 2019 Jun; 87():838-850. PubMed ID: 31003041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Derivatives of 4-methyl-1,2,3-benzoxathiazine 2,2-dioxide as selective inhibitors of human carbonic anhydrases IX and XII over the cytosolic isoforms I and II.
    Ivanova J; Abdoli M; Nocentini A; Žalubovskis R; Supuran CT
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2170370. PubMed ID: 36718988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, and biological investigation of selective human carbonic anhydrase II, IX, and XII inhibitors using 7-aryl/heteroaryl triazolopyrimidines bearing a sulfanilamide scaffold.
    Romagnoli R; De Ventura T; Manfredini S; Baldini E; Supuran CT; Nocentini A; Brancale A; Bortolozzi R; Manfreda L; Viola G
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2270180. PubMed ID: 37850364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, biological evaluation and in silico studies with 4-benzylidene-2-phenyl-5(4H)-imidazolone-based benzenesulfonamides as novel selective carbonic anhydrase IX inhibitors endowed with anticancer activity.
    Eldehna WM; Abdelrahman MA; Nocentini A; Bua S; Al-Rashood ST; Hassan GS; Bonardi A; Almehizia AA; Alkahtani HM; Alharbi A; Gratteri P; Supuran CT
    Bioorg Chem; 2019 Sep; 90():103102. PubMed ID: 31299596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ureidobenzenesulfonamides as Selective Carbonic Anhydrase I, IX, and XII Inhibitors.
    Denner TC; Angeli A; Ferraroni M; Supuran CT; Csuk R
    Molecules; 2023 Nov; 28(23):. PubMed ID: 38067512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inclusion of a 5-fluorouracil moiety in nitrogenous bases derivatives as human carbonic anhydrase IX and XII inhibitors produced a targeted action against MDA-MB-231 and T47D breast cancer cells.
    Petreni A; Bonardi A; Lomelino C; Osman SM; ALOthman ZA; Eldehna WM; El-Haggar R; McKenna R; Nocentini A; Supuran CT
    Eur J Med Chem; 2020 Mar; 190():112112. PubMed ID: 32044580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of coumarin-sulfonamide derivatives and determination of their cytotoxicity, carbonic anhydrase inhibitory and molecular docking studies.
    Zengin Kurt B; Sonmez F; Ozturk D; Akdemir A; Angeli A; Supuran CT
    Eur J Med Chem; 2019 Dec; 183():111702. PubMed ID: 31542715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural inspired ligustrazine-based SLC-0111 analogues as novel carbonic anhydrase inhibitors.
    Elimam DM; Eldehna WM; Salem R; Bonardi A; Nocentini A; Al-Rashood ST; Elaasser MM; Gratteri P; Supuran CT; Allam HA
    Eur J Med Chem; 2022 Jan; 228():114008. PubMed ID: 34871842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biological evaluation, radiosensitizing activity and structural insights of novel halogenated quinazoline-sulfonamide conjugates as selective human carbonic anhydrases IX/XII inhibitors.
    Ghorab MM; Soliman AM; Bua S; Supuran CT
    Bioorg Chem; 2021 Feb; 107():104618. PubMed ID: 33485104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of new ureido benzenesulfonamides incorporating 1,3,5-triazine moieties as carbonic anhydrase I, II, IX and XII inhibitors.
    Lolak N; Akocak S; Bua S; Sanku RKK; Supuran CT
    Bioorg Med Chem; 2019 Apr; 27(8):1588-1594. PubMed ID: 30846402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sulfonamide bearing pyrazolylpyrazolines as potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII.
    Khloya P; Ceruso M; Ram S; Supuran CT; Sharma PK
    Bioorg Med Chem Lett; 2015 Aug; 25(16):3208-12. PubMed ID: 26105196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies.
    Żołnowska B; Sławiński J; Szafrański K; Angeli A; Supuran CT; Kawiak A; Wieczór M; Zielińska J; Bączek T; Bartoszewska S
    Eur J Med Chem; 2018 Jan; 143():1931-1941. PubMed ID: 29146134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploration of 2-phenylquinoline-4-carboxamide linked benzene sulfonamide derivatives as isoform selective inhibitors of transmembrane human carbonic anhydrases.
    Swain B; Sahoo SK; Singh P; Angeli A; Yaddanapudi VM; Supuran CT; Arifuddin M
    Eur J Med Chem; 2022 Apr; 234():114247. PubMed ID: 35305463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.